These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7022966)

  • 1. Correlation of B-cell antibodies and clinical course in DRw-typed renal allograft recipients.
    Deierhoi MH; Radvany RM; Wolf JS
    Transplant Proc; 1981 Mar; 13(1 Pt 2):942-4. PubMed ID: 7022966
    [No Abstract]   [Full Text] [Related]  

  • 2. Warm B-cell antibodies and DRw matching: their influence on transplant outcome at a single center.
    Coxe-Gilliland R; Cross DE
    Transplant Proc; 1981 Mar; 13(1 Pt 2):945-8. PubMed ID: 7022967
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation.
    Le Bas-Bernardet S; Hourmant M; Valentin N; Paitier C; Giral-Classe M; Curry S; Follea G; Soulillou JP; Bignon JD
    Transplantation; 2003 Feb; 75(4):477-82. PubMed ID: 12605113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR matching and B-cell crossmatching in renal transplantation.
    Ting A; Williams KA; Morris PJ
    Transplant Proc; 1980 Sep; 12(3):495-501. PubMed ID: 7013181
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction between panel reactive antibodies, auto- and cold reactive antibodies, and a positive B cell cross-match in renal and cardiac allograft survival.
    Creemers P; Brink J; Kahn D
    Clin Transplant; 1997 Apr; 11(2):134-8. PubMed ID: 9113450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss.
    Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF
    Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of the IgG anti-B-cell crossmatch on renal transplant outcome.
    Ghasemian SR; Light JA; Currier CB; Sasaki T; Aquino A; Rees J; Ward W; Carr J
    Clin Transplant; 1997 Oct; 11(5 Pt 2):485-7. PubMed ID: 9361946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
    Süsal C; Döhler B; Opelz G
    Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood transfusions and their influence on renal allograft survival.
    Rodey GE
    Prog Hematol; 1986; 14():99-122. PubMed ID: 3511519
    [No Abstract]   [Full Text] [Related]  

  • 10. HLA-D antigen disparity and HLA-DRw antibodies in intrafamilial renal allograft survival.
    Cochrum K; Hanes D; Van Speybroeck J; Perkins H; Ferrone S; Indeveri F; Amend W; Vincenti F; Feduska N; Salvatierra O
    Transplant Proc; 1979 Mar; 11(1):404-10. PubMed ID: 156426
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple specificities of B lymphocyte-reactive antibodies and their significance in renal allograft survival.
    Rhodes CL; Goldman MH; Mendez-Picon G; Lee HM; Mohanakumar T
    Transplant Proc; 1984 Dec; 16(6):1425-6. PubMed ID: 6390841
    [No Abstract]   [Full Text] [Related]  

  • 12. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome.
    Praticò-Barbato L; Conca R; Magistroni P; Leonardi G; Oda A; Rosati F; Leone E; Tacconella M; Roggero S; Segoloni GP; Amoroso A
    Transpl Immunol; 2008 Jul; 19(3-4):238-43. PubMed ID: 18675725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperacute rejection from antibody against class II HLA antigens.
    Ghasemian SR; Light JA; Sasaki TA; Barhyte DY
    Clin Transplant; 1998 Dec; 12(6):569-71. PubMed ID: 9850452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for DR sharing in stable kidney allograft tolerance induced by donor bone marrow in rhesus monkeys.
    Thomas J; Kasten-Jolly J; Verbanac K; Smith JP; Carver M; Gross U; Rebellato L; Thomas F; Haisch C
    Transplant Proc; 1995 Feb; 27(1):686-8. PubMed ID: 7879146
    [No Abstract]   [Full Text] [Related]  

  • 16. HLA-DRW6 and autoantibodies in recipients of first kidney grafts.
    Reekers P; Raaben W; van der Beucken M; Kunst V; Hoitsma A; Koene R
    Transplant Proc; 1984 Oct; 16(5):1159-61. PubMed ID: 6385364
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class II antigens and interleukin 2 expression in renal allograft recipients.
    Glapinski T; Lao M; Wasik M; Lagodzinski Z; Nowaczyk M; Gorski A
    Transplant Proc; 1989 Feb; 21(1 Pt 1):319. PubMed ID: 2650133
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical value of HLA-DRB1 typing in cadaveric renal transplantation.
    Kobayashi T; Negita M; Yokoyama I; Kamura H; Kohara S; Ohshima S; Fujita T; Ono Y; Kinukawa T; Hoshinaga K
    Transplant Proc; 1993 Dec; 25(6):3271-2. PubMed ID: 8266538
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of B-cold lymphocytotoxins to enhance cadaveric renal allograft survival.
    Mendez R; Chatterjee SN; Mendez R; Bogaard T
    Transplantation; 1985 Sep; 40(3):253-6. PubMed ID: 3898490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.